Showing 1 - 2 results of 2 for search 'Jen-Yu Hung', query time: 0.01s Refine Results
  1. 1
    The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations

    The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 2... by Chih-Jen Yang, Ming-Ju Tsai, Jen-Yu Hung, Mei-Hsuan Lee, Ying-Ming Tsai, Yu-Chen Tsai, Jui-Feng Hsu, Ta-Chih Liu, Ming-Shyan Huang, Inn-Wen Chong

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy

    The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemo... by Chih-Jen Yang, Jen-Yu Hung, Ming-Ju Tsai, Kuan-Li Wu, Ta-Chih Liu, Shah-Hwa Chou, Jui-Ying Lee, Jui-Sheng Hsu, Ming-Shyan Huang, Inn-Wen Chong

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: